Delfi Diagnostics
Delfi Diagnostics is a biotechnology company specializing in cancer detection through advanced machine learning algorithms that analyze cell-free DNA from blood samples. The company is conducting a large clinical trial, CASCADE-LUNG, and offers the FirstLook blood test for lung cancer screening, with labs and offices in Baltimore, MD, and Palo Alto, CA.
Company Overview
Delfi Diagnostics is a biotechnology company specializing in cancer detection through innovative machine learning algorithms. The company utilizes advanced techniques to analyze fragments of cell-free DNA from blood samples, aiming to identify cancer-associated markers that traditional methods may overlook. Delfi Diagnostics’ operations span labs and offices in Baltimore, MD, and Palo Alto, CA.
Clinical Trials: CASCADE-LUNG
Delfi Diagnostics is currently enrolling approximately 15,000 participants in its landmark clinical trial, CASCADE-LUNG. This trial aims to validate the company's revolutionary approach to lung cancer screening by leveraging its advanced machine learning systems to analyze blood samples for early detection. The scale of this trial underscores Delfi's commitment to pioneering highly accurate and non-invasive cancer detection methods.
Product Highlight: FirstLook Blood Test
The FirstLook blood test, developed by Delfi Diagnostics, represents a significant advance in lung cancer screening. This test offers a convenient and personalized approach to detecting lung cancer, boasting a negative predictive value of 99.8%. By analyzing a multitude of molecular data points, FirstLook can provide deeper clinical insights than conventional methods. This product aims to make early cancer detection more accessible and effective.
Collaborations and Partnerships
Delfi Diagnostics collaborates with several prestigious institutions to enhance cancer screening technologies and accessibility. Key partnerships include OSF HealthCare and the City of Hope, focusing on improving lung cancer screening rates, particularly in underserved areas of Los Angeles. The company also partners with Memorial Sloan Kettering Cancer Center and serves as the liquid biopsy partner for the 4-IN-THE-LUNG-RUN European lung cancer screening study.
Employee Benefits and Work Culture
Delfi Diagnostics places a strong emphasis on employee well-being and work-life balance. The company offers several generous benefits, including 100% coverage of medical premiums for employees and their families, 16 weeks of paid parental leave, and hybrid or remote work options. Additionally, Delfi supports professional growth through wide-ranging learning and development programs. The company provides a one-time $400 subsidy for home office setup, ensuring that remote employees are well-equipped.